Series C financing – Talk Bio

Actionable Insights Powered by AI

Evommune Files for IPO to Fund Phase 2 Trials of Autoimmune Drug Candidates

2 weeks ago talkbio0Tagged autoimmune drugs, Chronic inflammatory disorder, EVO301, EVO756, Evommune, Funding, IPO, New York Stock Exchange, Phase 2 Trials, Series C financing

Evommune; IPO; Phase 2 trials; autoimmune drugs; EVO756; EVO301; chronic inflammatory diseases; biotech funding; New York Stock Exchange; Series C financing

Novo Holdings Spearheads $100M Series C Financing for SiteOne Therapeutics to Develop Non-Opioid Pain Therapies

10 months ago talkbio0Tagged Holdings, ion channel modulators, Non-Opioid Pain, Opioid Epidemic, pain chronic management, Peripheral Nervous System, Series C financing, SiteOne Therapeutics

Novo Holdings, SiteOne Therapeutics, Non-opioid pain treatments, Series C financing, Ion channel modulators, Peripheral nervous system (PNS) pain treatments, Chronic pain management, Opioid epidemic